---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-229280"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2022-08-25T23:59:59+00:00"
generated_at: "2026-06-23T21:28:27.134394+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rani Therapeutics enters $150M ATM equity offering agreement with Cantor and H.C. Wainwright

## Summary
- Up to $150M of Class A common stock may be sold at market prices on Nasdaq through agents Cantor Fitzgerald and H.C. Wainwright.
- Agent compensation set at up to 3.0% of gross sales price per share sold.
- Offering under effective shelf registration (Form S-3, effective Aug 10, 2022); prospectus supplement filed Aug 24, 2022.
- Rani not obligated to sell any shares; agreement may be terminated by either party with 10 days' notice.

## SEC filing metadata
- accession: 0001193125-22-229280
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2022-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/0001193125-22-229280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000119312522229280/d385381d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-229280
- JSON: https://secwatch.observer/filing/0001193125-22-229280.json
- Plain text: https://secwatch.observer/filing/0001193125-22-229280.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.